CHI3L1 and neoplasm: Therefore, 4T1 tumor-bearing mice were treated with either chitin (every 3 d), anti-CHI3L1 or IgG control antibodies (weekly) for 2 w until 5 w p.i., and tumor progression was monitored through tumor volume measurements (Fig. 9A).